Filter
4835
Filtered Results: 4835
Text search:
Epidemiologia
Featured
Recommendations
417
New Publications
1106
Language
Document type
No document type
2542
Studies & Reports
827
Guidelines
800
Manuals
208
Strategic & Response Plan
203
Fact sheets
105
Situation Updates
72
Training Material
41
Resource Platforms
15
Online Courses
9
Infographics
8
Brochures
3
Dashboards/Maps
1
Videos
1
Countries / Regions
Global
196
India
170
Latin America and the Carribbean
162
Brazil
132
Western and Central Europe
130
Sierra Leone
99
Indonesia
87
Liberia
85
Africa
77
Paraguay
76
Colombia
73
Kenya
71
Nigeria
71
Argentina
70
Venezuela
69
Ethiopia
69
South Africa
67
Mozambique
65
Eastern Europe
55
Rwanda
53
Uganda
53
Nepal
47
Russia
45
Ghana
44
Peru
43
Bolivia
42
Congo, Democratic Republic of
41
Malawi
40
Guinea
38
Zambia
38
Bangladesh
37
Ukraine
34
Chile
31
Tanzania
30
Ecuador
30
Myanmar / Burma
29
West and Central Africa
28
Asia
27
Senegal
26
Philippines
26
Germany
26
South–East Asia Region
26
Angola
26
Namibia
24
Syria
23
Haiti
23
East and Southern Africa
23
El Salvador
20
Eastern Europe and Central Asia
20
Middle East and North Africa
19
Yemen
19
Zimbabwe
18
Pakistan
18
Madagascar
17
Lesotho
16
Cambodia
16
Benin
14
Guinea-Bissau
14
Albania
13
Spain
13
Botswana
13
Tajikistan
12
Cameroon
12
Burkina Faso
12
Western Pacific Region
11
Mali
10
Eswatini/ Swaziland
10
Afghanistan
9
Somalia
9
China
8
Côte d’Ivoire / Ivory Coast
8
Sudan
8
Central African Republic
8
Moldova
7
Honduras
7
South Sudan
7
Togo
6
Italy
6
USA
6
North America
6
Georgia
6
Gambia
5
Southern Africa
5
Lebanon
5
Vietnam
5
Thailand
4
Kyrgyzstan
4
Niger
4
Armenia
4
Dominican Republic
4
Jordan
4
Saudi Arabia
4
France
4
Chad
4
Iraq
4
Guatemala
4
North Macedonia
3
Mexico
3
Kazakhstan
3
Burundi
3
Uruguay
3
Turkmenistan
3
Portugal
3
Sri Lanka
3
Djibouti
3
Egypt
3
Timor Leste/ East Timor
2
Serbia
2
Turkey
2
Iran
2
Laos
2
Estonia
2
Uzbekistan
2
Ireland
2
Jamaica
2
Mauritius
2
United Kingdom
2
Belarus
2
Bosnia and Herzegovina
2
Greece
2
Palestine
2
Poland
2
Libya
2
Bhutan
2
North Korea
1
Australia
1
Singapore
1
Congo-Brazzaville
1
Morocco
1
Qatar
1
Mauritania
1
Lithuania
1
Maldives
1
Tunisia
1
Nicaragua
1
Romania
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1850
Clinical Guidelines
409
Public Health
271
Key Resources
120
Women & Child Health
119
Pharmacy & Technologies
59
Capacity Building
39
Toolboxes
COVID-19
719
TB
450
HIV
373
Mental Health
317
Rapid Response
297
NTDs
218
Ebola
184
Planetary Health
143
AMR
118
Zika
102
NCDs
97
Disability
57
Polio
55
Cholera
54
Global Health Education
49
Caregiver
45
Conflict
44
Refugee
40
Pharmacy
40
Natural Hazards
33
Health Financing Toolbox
28
Specific Hazards
19
Social Ethics
5
Typhoon
3
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
Worldwide, there are about 17 million deaths due to cardiovascular disease (CVD) each year and at least two or three times as many non-fatal events. Raised cholesterol greatly increases the risks of stroke and heart disease, causing a large
health burden across the world. The World Health Organizat...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was to analyze the trend in CVD incidence, mortality, and mortality-to-...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Cholera is an acute gastrointestinal infection caused by the bacterium Vibrio Cholerae serogroup O1 or O139, and is often linked to unsafe drinking water, lack of proper sanitation and personal hygiene. It adversely affects mostly the poor and vulnerable populations in countries, which are already d...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its variation within countries by socio-demographic char...
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known about the required training necessary for them to ...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a...
Background
Noncommunicable diseases are major contributors to morbidity and mortality worldwide. Modifying the risk factors for these conditions, such as physical inactivity, is thus essential. Addressing the context or circumstances in which physical activity occurs may promote physical activity a...
